Eden Research EDEN.L · GBp

Its shares trade on LSE under the ticker EDEN.L. It has been listed since 11 May 2012. In the fiscal year to 31 March 2026, it reported revenue of £3.9m and a net loss of £2.0m. At that date it held total assets of £16.3m and shareholders' equity of £12.4m.

Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Cirencester, Gloucestershire. The company went IPO on 2012-05-11. The firm focuses on plant protection, animal and human health, and biocides. The firm's segments include Biocides, Human health and Agrochemicals. The company offers a range of product categories, such as Foliar Diseases Control, including Botrytis, Botrytis Trail Data and Powdery Mildew; Soil Pest, including Nematodes and New Nematode Data; Protected Glass House Crops, including Spider Mites, Spider Mite Trail Data, Whitefly, Whitefly Trail Data and Powdery Mildew; Vascular Diseases Control, including Esca, Eutypa and Pierce's Diseases, and Post-Harvest Applications. Its encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Lykele Van Der BroekNon-Executive Independent Chairman of the Board£45,000
• Mr. Sean SmithChief Executive Officer, Executive Director, since 2014£496,519
• Mr. Alex AbreyChief Financial Officer, Executive Director, Secretary, since 2007£373,004
• Mr. Robin CridlandNon-Executive Independent Director£40,000
• Mr. Derek McallanNon-Executive Independent Director£26,254

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.